Silver Nanoparticles in Multidrug Resistant Bacteria

Assiut University150 enrolled

Overview

Recently, silver nanoparticles (AgNPs) have been widely used in various applications as antimicrobial agents, anticancer, diagnostics, biomarkers, cell labels, and drug delivery systems for the treatment of various diseases. The present study investigated the bactericidal effect of AgNPs against Methecillin Resistant Staph. aureus (MRSA) and Vancomycin resistant Staph aureus (VRSA)

Study Type

OBSERVATIONAL

Enrollment

150

Conditions

Multidrug Resistent Bacteria

Interventions

silver nanoparticlesOTHER

effect silver nanoparticles will be examined on multidrug resistant bacteria

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Intensive care patients Exclusion Criteria: * none

Locations (1)

Assiut university

Asyut, Egypt

Outcomes

Primary Outcomes

bactericidal effect of silver nanoparticles on multidrug resistant bacteria

Time frame: 24 hours

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.